SCHEMBL3872066

SCHEMBL3872066

CCOC(=O)c1ccc2c(c1)NCC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 3/20 0.51
MAPK1 P28482 2/20 0.51
PLK4 O00444 1/20 0.51
DAPK3 O43293 1/20 0.51
DYRK3 O43781 1/20 0.51
PRKD3 O94806 1/20 0.51
MAP4K4 O95819 1/20 0.51
PIM1 P11309 1/20 0.51
RPS6KB1 P23443 1/20 0.51
CDK2 P24941 1/20 0.51
KDR P35968 1/20 0.51
MAPK8 P45983 1/20 0.51
CLK2 P49760 1/20 0.51
GSK3B P49841 1/20 0.51
CDK5 Q00535 1/20 0.51
DYRK1A Q13627 1/20 0.51
PIM3 Q86V86 1/20 0.51
MINK1 Q8N4C8 1/20 0.51
AURKB Q96GD4 1/20 0.51
PBK Q96KB5 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29968115 1.00 JAK2 (0.51) JAK2MAPK1PLK4DAPK3DYRK3
Hydrochloric Acid SCHEMBL27081766 0.99 JAK2 (0.50) JAK2MAPK1PLK4DAPK3DYRK3
SCHEMBL3571275 0.86 RAB9A (0.57) MAPK1ALDH1A1ALOX15MAPTKDM4E
SCHEMBL1513343 0.86 JAK2 (0.55) JAK2JAK3POLBHPGD
SCHEMBL2898350 0.83 ALDH1A1 (0.47) ALDH1A1CA12CA1CA2CA7
SCHEMBL29906783 0.83 ALDH1A1 (0.47) ALDH1A1CA12CA1CA2CA7
SCHEMBL28447448 0.83 ACHE (0.39) JAK2MAPK1PLK4DAPK3DYRK3
Hydrochloric Acid SCHEMBL29940234 0.82 ALDH1A1 (0.46) ALDH1A1CA12CA1CA2CA7
Hydrochloric Acid SCHEMBL3102567 0.82 ALDH1A1 (0.46) ALDH1A1CA12CA1CA2CA7
SCHEMBL30782284 0.82 MAPK1 (0.57) JAK2MAPK1PLK4DAPK3DYRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313972-B1 INDOLINE DERIVATIVES AS DDRS INHIBITORS CHIESI FARM SPA (IT) 2025-01-29 EP disclosed
US-20240217967-A1 INDOLINE DERIVATIVES AS DDRS INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-07-04 US disclosed
EP-4313972-A1 INDOLINE DERIVATIVES AS DDRS INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2024-02-07 EP disclosed
CN-117062812-A Indoline derivatives as DDR inhibitors 奇斯药制品公司 2023-11-14 CN disclosed
US-8188139-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
EP-1848694-B1 HETEROCYCLIC SUBSTITUTED PHENYL METHANONES AS INHIBITORS OF THE GLYCINE TRANSPORTER 1 HOFFMANN LA ROCHE (CH) 2009-11-25 EP disclosed
US-20090203665-A1 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES JOLIDON SYNESE 2009-08-13 US disclosed
US-7557114-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2009-07-07 US disclosed
US-20060178381-A1 Heterocyclic-substituted phenyl methanones HOFFMANN-LA ROCHE INC. 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203665-A1 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES CYP2B6, CYP2D6, CYP1A2 JAK2 560/4885MAPK1 2206/4885PLK4 1797/4885
US-20060178381-A1 Heterocyclic-substituted phenyl methanones CYP2B6, CYP2D6, CYP1A2 JAK2 560/4885MAPK1 2206/4885PLK4 1797/4885
US-20240217967-A1 INDOLINE DERIVATIVES AS DDRS INHIBITORS DDR1, DDR2, DDRGK1 JAK2 1089/4885MAPK1 893/4885PLK4 1422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.